{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-005793","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.509823+00:00","generated_at":"2026-05-16T04:16:31.859368+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BD reorganizes into five segments; provides recast historical revenue data","bullets":["New segments effective Oct 1, 2025: Medical Essentials, Connected Care, BioPharma Systems, Interventional, Life Sciences.","Life Sciences segment to be eliminated after planned combination of Biosciences/Diagnostic Solutions with Waters Corp (announced July 13, 2025).","Exhibit 99.1 furnishes recast segment revenues for FY2025 and quarterly periods, including non-GAAP measures.","Segment reorganization does not affect principal product lines of any organizational unit."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-005793","json":"https://secwatch.observer/filing/0001628280-26-005793.json","markdown":"https://secwatch.observer/filing/0001628280-26-005793.md","text":"https://secwatch.observer/filing/0001628280-26-005793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000162828026005793/0001628280-26-005793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000162828026005793/bdx-20260205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:16:31.859368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}